Mahdi Garelnabi to Cardiovascular Diseases
This is a "connection" page, showing publications Mahdi Garelnabi has written about Cardiovascular Diseases.
Connection Strength
1.609
-
Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
Score: 0.570
-
McGrail L, Garelnabi M. Polyphenolic Compounds and Gut Microbiome in Cardiovascular Diseases. Curr Pharm Biotechnol. 2020; 21(7):578-586.
Score: 0.494
-
Garelnabi M, Lor K, Jin J, Chai F, Santanam N. The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research. Clin Biochem. 2013 Jan; 46(1-2):12-9.
Score: 0.298
-
Garelnabi M, Veledar E, Abramson J, White-Welkley J, Santanam N, Weintraub W, Parthasarathy S. Physical inactivity and cardiovascular risk: baseline observations from men and premenopausal women. J Clin Lab Anal. 2010; 24(2):100-5.
Score: 0.247